Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
{{output}}
Background: The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the cardiovascular efficac... ...
